Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2000
10/19/2000WO2000061625A1 48 human secreted proteins
10/19/2000WO2000061624A1 48 human secreted proteins
10/19/2000WO2000061623A1 62 human secreted proteins
10/19/2000WO2000061622A2 Genes associated with diseases of the kidney
10/19/2000WO2000061621A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061619A1 Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof
10/19/2000WO2000061618A1 Fab-EPITOPE COMPLEX FROM THE HIV-1 CROSS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5
10/19/2000WO2000061617A2 Transiently immortalized cells for use in gene therapy
10/19/2000WO2000061616A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
10/19/2000WO2000061615A2 Homologs of mar-binding filament-like protein 1 (mfp1)
10/19/2000WO2000061614A2 Uncoupling proteins
10/19/2000WO2000061612A2 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000WO2000061611A2 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
10/19/2000WO2000061610A2 Prostate-restricted gene 30p3c8 expressed in prostate cancer
10/19/2000WO2000061607A1 Separation of plasma components
10/19/2000WO2000061606A1 Novel human voltage-gated potassium channel
10/19/2000WO2000061605A1 Dna encoding the prostate-specific membrane antigen-like gene and uses thereof
10/19/2000WO2000061598A2 Rat kidney specific gene profilin-3
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061525A1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
10/19/2000WO2000061230A2 Estrogen receptors-beta antagonism and bone diseases
10/19/2000WO2000061194A2 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
10/19/2000WO2000061170A2 Novel medical use of alpha-1-acidic glycoprotein (aag or orosomucoid)
10/19/2000WO2000061165A1 Conserved adhesin motif and methods of use thereof
10/19/2000WO2000061164A1 Modulation of excitable tissue function by peripherally administered erythropoietin
10/19/2000WO2000061069A2 Methods and compositions for use in the treatment of hyperlipidemia
10/19/2000WO2000061067A2 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
10/19/2000WO2000060945A1 SOLUBLE RECOMBINANT ENDOSTATIN AND METHOD OF MAKING SAME FROM $i(STREPTOMYCES SP)
10/19/2000WO2000060943A1 Prevention of brain damage in stroke
10/19/2000WO2000060932A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1
10/19/2000WO2000039280A8 Leukocyte-derived interferon preparations
10/19/2000WO2000037641A3 Vascular endothelial growth factor-x
10/19/2000WO2000036093A3 Intein-mediated cyclization of peptides
10/19/2000WO2000036083A3 Pkc-interacting cousin of trx (picot) polypeptides, polynucleotides, and methods of making and using them
10/19/2000WO2000035952A3 Compounds for control of eating, growth and body weight
10/19/2000WO2000034780A3 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3?
10/19/2000WO2000034308A3 Protein transduction system and methods of use thereof
10/19/2000WO2000033872A3 Method of and compositions for immunization with the pseudomonas v antigen
10/19/2000WO2000032778A3 Methods and compositions for inhibiting neoplastic cell growth
10/19/2000WO2000032769A3 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
10/19/2000WO2000032626A8 Methods of using epitope peptides of human pathogens
10/19/2000WO2000032208A3 Isolated material having an anti-organotrophic effect
10/19/2000WO2000031279A3 Producing antimicrobial cationic peptides as fusion proteins
10/19/2000WO2000031264A3 Testis-specific cystatin-like protein cystatin t
10/19/2000WO2000031125A3 REGULATORY PROTEIN pKe#83 FROM HUMAN KERATINOCYTES
10/19/2000WO2000030453A3 Insecticidal agents
10/19/2000WO2000028067A9 Enzymatic amidation of peptides
10/19/2000WO2000026368A9 Therapeutic antiangiogenic endostatin compositions
10/19/2000WO2000024757A9 Human retinoid-like orphan receptor gamma
10/19/2000WO2000023625A3 Isolated nucleic acid molecules which encode scp proteins, and uses thereof
10/19/2000WO2000019883A9 Compositions and methods of disease diagnosis and therapy
10/19/2000WO2000012732A3 Organelle targeting sequences
10/19/2000WO2000004155A9 Compositions and methods for enhancing disease resistance in plants
10/19/2000WO1999063088A8 Membrane-bound proteins and nucleic acids encoding the same
10/19/2000DE19917713A1 Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik Short-chain peptide-dye conjugates as contrast agents for optical diagnostics
10/19/2000DE19917195A1 New peptide derived from the MUC-1 tumor marker, used to induce a cytotoxic T cell response for treatment or prevention of tumors
10/19/2000DE19917098A1 New immunogenic polypeptides from methicillin-resistant Staphylococcus aureus, useful for raising human antibodies for treating infections
10/19/2000DE19917084A1 Inhibiting cell cycle and cell growth, useful e.g. for protecting neuronal cells, by expressing an inhibitor of nuclear factor-kappaB in transdominant negative form
10/19/2000DE19915485A1 Therapie der Herzinsuffizienz Treatment of heart failure
10/19/2000CA2815763A1 Anti-bacterial vaccine compositions
10/19/2000CA2815566A1 Pasteurellaceae bacteria comprising a mutated virulence gene and an anti-bacterial vaccine prepared therefrom
10/19/2000CA2760534A1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000CA2383940A1 Modulation of excitable tissue function by peripherally administered erythropoietin
10/19/2000CA2372028A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000CA2371941A1 Method of purifying heterologous proteins
10/19/2000CA2371929A1 Fab'-epitope complex from the hiv-1 cross-neutralizing monoclonal antibody 2f5
10/19/2000CA2371223A1 49 human secreted proteins
10/19/2000CA2371172A1 50 human secreted proteins
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370563A1 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
10/19/2000CA2370562A1 49 human secreted proteins
10/19/2000CA2370523A1 49 human secreted proteins
10/19/2000CA2370489A1 49 human secreted proteins
10/19/2000CA2370237A1 Methods for the diagnosis and treatment of metastatic prostate tumors
10/19/2000CA2370189A1 48 human secreted proteins
10/19/2000CA2370131A1 62 human secreted proteins
10/19/2000CA2370112A1 Uncoupling proteins
10/19/2000CA2370039A1 Apoptosis-associated gene
10/19/2000CA2370033A1 Dna encoding the prostate-specific membrane antigen-like gene and uses thereof
10/19/2000CA2370018A1 Complex formed by n-linked glycoproteins (siblings) and factor h
10/19/2000CA2369908A1 Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof
10/19/2000CA2369827A1 Separation of plasma components
10/19/2000CA2369822A1 Novel human voltage-gated potassium channel
10/19/2000CA2369817A1 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences
10/19/2000CA2369629A1 Method to type prion proteins
10/19/2000CA2369578A1 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000CA2369472A1 Novel medical use of alpha-1-acidic glycoprotein (aag or orosomucoid)
10/19/2000CA2369413A1 Transmembrane protein expressed in prostate and other cancers
10/19/2000CA2369384A1 Prostate-restricted gene 30p3c8 expressed in prostate cancer
10/19/2000CA2369262A1 Pulmonary administration of dry powder formulations for treating infertility
10/19/2000CA2369200A1 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
10/19/2000CA2369156A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1
10/19/2000CA2369029A1 Poly(dipeptide) as a drug carrier
10/19/2000CA2369027A1 Ecotine derivatives
10/19/2000CA2368937A1 Prevention of brain damage in stroke
10/19/2000CA2368648A1 Estrogen receptors and bone
10/19/2000CA2368490A1 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
10/19/2000CA2366520A1 Anti-bacterial vaccine compositions
10/19/2000CA2366359A1 Novel essential bacterial genes and their proteins
1 ... 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 ... 2916